IMPACT 2017 | Parker Institute for Cancer Immunotherapy -Tumor Epitope Selection Alliance (TESLA)

from CHI Podcasts · host Cambridge Healthtech Podcasts

Danny Wells speaks to CHI on July 6th, 2017. Dr. Wells will be speaking during Neoantigen-Based Personalized Immunotherapies meeting at ImPACT: Immunotherapy Progress and Clinical Treatments, December 5-7th, 2018 in San Diego, California. Topics include scaling up personalized therapies, future clinical applications of neoantigens, and new frontiers in cancer immunotherapy. For more information, please visit http://www.ImpactImmunotherapy.com/Neoantigen-Immunotherapy/

Episode metadata supplied by the publisher feed · Published Jul 28, 2017

Embed this episode

Attribution link and audio player

NOW PLAYING

IMPACT 2017 | Parker Institute for Cancer Immunotherapy -Tumor Epitope Selection Alliance (TESLA)

0:00 13:40

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of CHI Podcasts?

This episode is 13 minutes long.

When was this CHI Podcasts episode published?

This episode was published on July 28, 2017.

Can I download this CHI Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!